United Kingdom · Question · Written question
UIN 190164
Trastuzumab Deruxtecan
Original
Introduced
19 June 2023
Last action
26 June 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
26 June 2023
Summary
To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence is taking steps to approve Enhertu for use in the treatment of cancers other than breast cancer.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 June 2023
Written question
To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence is taking steps to approve Enhertu for use in the treatment of cancers other than breast cancer.
Source: Commons
26 June 2023
Answer
The National Institute for Health and Care Excellence (NICE) is currently in the early stages of developing technology appraisal guidance on treatments for non-small-cell lung cancer, including Enhertu (trastuzumab deruxtecan) and held a scoping workshop ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-06-19/190164
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1645697
- uk · wq-1645697 · source updated 26 June 2023